Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC).

Hayat Oum El Kheir Ramdani, Markus Falk, Stefanie Schatz, Markus Tiemann, Lukas Heukamp, Ed Schuuring, Harry J. M. Groen, Frank Griesinger

    Research output: Contribution to journalMeeting AbstractAcademic

    Original languageEnglish
    Number of pages1
    JournalJournal of Clinical Oncology
    Volume37
    Issue number15
    DOIs
    Publication statusPublished - 20-May-2019
    EventAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, Israel
    Duration: 31-May-20194-Jun-2019

    Cite this